ALMS logo

ALMS
Alumis Inc.

1,059
Mkt Cap
$2.81B
Volume
874,134.00
52W High
$30.60
52W Low
$2.76
PE Ratio
-11.47
ALMS Fundamentals
Price
$22.17
Prev Close
$22.04
Open
$21.90
50D MA
$24.08
Beta
0.91
Avg. Volume
1.27M
EPS (Annual)
-$2.86
P/B
4.95
Rev/Employee
$107,366.07
$558.22
Loading...
Loading...
News
all
press releases
Alumis Stock Has Soared 400%. Cormorant Bought Another $8 Million Last Quarter
Key PointsCormorant bought 313,645 additional Alumis shares in the first quarter; the estimated trade size was $7.84 million (using average prices in the quarter...
Nasdaq News: Markets·4d ago
News Placeholder
More News
News Placeholder
Alumis Stock Is Up Over 300%. One Major Healthcare Investor Is Cutting Back
Key PointsOmega Fund Management sold 411,968 shares of Alumis; the estimated trade value is $10.3 million (based on quarterly average price...
Nasdaq News: Markets·6d ago
News Placeholder
This Alumis Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday
Top analysts changed outlook on top names. See all rating changes on analyst ratings page. Check out analysts' views on ALMS stock.read more...
Benzinga·6d ago
News Placeholder
C4 Therapeutics, Inc. (CCCC) Reports Q1 Loss, Lags Revenue Estimates
C4 Therapeutics (CCCC) delivered earnings and revenue surprises of +4.76% and -5.35%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks·9d ago
News Placeholder
Why One Fund's $4 Million Alumis Buy Looks Like a Bet on a Breakthrough Autoimmune Drug
Key PointsACT Capital Management acquired 174,250 ALMS shares in the first quarter, with an estimated trade value of $4.36 million based on average first-quarter pricing...
Nasdaq News: Markets·12d ago
News Placeholder
Personalis (PSNL) Reports Q1 Loss, Tops Revenue Estimates
Personalis (PSNL) delivered earnings and revenue surprises of -26.09% and +7.56%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks·14d ago
News Placeholder
Alumis Inc. (NASDAQ:ALMS) Receives Consensus Recommendation of "Moderate Buy" from Analysts
Alumis Inc. (NASDAQ:ALMS - Get Free Report) has been assigned an average rating of "Moderate Buy" from the twelve analysts that are covering the stock, Marketbeat reports. One investment analyst has rated the stock with a sell rating, ten have given a buy rating and one has assigned a strong buy...
MarketBeat·1mo ago
News Placeholder
Alumis Inc. (NASDAQ:ALMS) Short Interest Up 25.3% in March
Alumis Inc. (NASDAQ:ALMS - Get Free Report) was the target of a large increase in short interest during the month of March. As of March 31st, there was short interest totaling 11,230,693 shares, an increase of 25.3% from the March 15th total of 8,963,277 shares. Based on an average daily trading...
MarketBeat·1mo ago
News Placeholder
Alumis Inc. $ALMS Shares Sold by Trium Capital LLP
Trium Capital LLP lessened its stake in Alumis Inc. (NASDAQ:ALMS - Free Report) by 71.4% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The...
MarketBeat·1mo ago
News Placeholder
Alumis (NASDAQ:ALMS) Shares Down 4.1% - Here's What Happened
Alumis (NASDAQ:ALMS) Stock Price Down 4.1% - Should You Sell...
MarketBeat·2mo ago
<
1
2
...
>

Latest ALMS News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.